Michela Cimberle

KIAWAH ISLAND, S.C. — In a study presented at Kiawah Eye, instrument-based screening for amblyopia risk factors and refractive error showed different sensitivity levels depending on ethnicity or eye coloration.

KIAWAH ISLAND, S.C. — Drug-eluting implants in various stages of study and approval may provide efficient, sustained drug delivery, overcoming barriers to penetration, according to a speaker at Kiawah Eye.

Donating time to serve those in need by volunteering abroad can be a personal life-changing experience as well as a meaningful contribution to the health and social well-being of disadvantaged communities.

Key takeaways: CTR implantation reduces IOL decentration and tilt in highly myopic eyes with an axial length of 30 mm or longer.

A review of currently available data suggests that there is little or no difference in efficacy and safety between anti-VEGF biosimilars approved for neovascular age-related macular degeneration and their reference products.

PARK CITY, Utah — Stage one of the phase 3 DIAMOND trial of OCS-01 , a high-concentration dexamethasone eye drop for diabetic macular edema, showed promising safety and efficacy outcomes. Stage two of the trial is underway.

PARK CITY, Utah — Outcomes from the phase 1/2a HORNBILL study indicate a potential disease-modifying effect of BI 764524 in eyes with diabetic macular ischemia.

The first analysis of real-world outcomes in patients with neovascular age-related macular degeneration treated with pegcetacoplan for geographic atrophy demonstrated similar safety seen in clinical trials, according to a study.

Key takeaways: Atropine eye drops showed efficacy in slowing myopia progression. The use of atropine did not aggravate intermittent exotropia.

Key takeaways: A panel of experts published guidelines on suprachoroidal space injection. The guidelines promote current best evidence and clinical experience.